| 000 | 01045 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515000904.0 | ||
| 264 | 0 | _c20051019 | |
| 008 | 200510s 0 0 fre d | ||
| 022 | _a0035-3787 | ||
| 024 | 7 |
_a10.1016/s0035-3787(05)85103-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCorvol, J-C | |
| 245 | 0 | 0 |
_a[Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations]. _h[electronic resource] |
| 260 |
_bRevue neurologique _cJul 2005 |
||
| 300 |
_a637-43 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Guideline; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 |
_aHeart Valve Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPergolide _xadverse effects |
| 700 | 1 | _aSchüpbach, M | |
| 700 | 1 | _aBonnet, A-M | |
| 773 | 0 |
_tRevue neurologique _gvol. 161 _gno. 6-7 _gp. 637-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0035-3787(05)85103-3 _zAvailable from publisher's website |
| 999 |
_c15777478 _d15777478 |
||